Chemomab Therapeutics Ltd. Weighted Average Remaining Contractual Life Of Outstanding Share Options
Chemomab Therapeutics Ltd. (CMMB) had Weighted Average Remaining Contractual Life Of Outstanding Share Options of 8.1 Year as of 2018-12-31, per its 20-F filed 2019-04-24.
Discontinued › Notes
ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions · last filed 2019-04-24
- 2018-12-31: Weighted Average Remaining Contractual Life Of Outstanding Share Options 8.10 Year.
- 2017-12-31: Weighted Average Remaining Contractual Life Of Outstanding Share Options 8.80 Year.
| Period end | Weighted Average Remaining Contractual Life Of Outstanding Share Options |
|---|---|
| 2018-12-31 | 8.10 Year 20-F · filed 2019-04-24 |
| 2017-12-31 | 8.80 Year 20-F · filed 2019-04-24 |